ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,745, issued on Aug. 25, was assigned to BAYLOR RESEARCH INSTITUTE (Dallas).

"Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)" was invented by SangKon Oh (Baltimore), Dapeng Li (Davis, Calif.), Jacques Banchereau (Montclair, N.J.), Gerard Zurawski (Midlothian, Texas) and Sandra Zurawski (Midlothian, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes compositions and methods for making and using anti DC-ASGPR antibodies that can, e.g., activate DCs and other cells."

The patent was filed on May 21, 2024, under Application No. 18/670,211.

*For further informatio...